Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study
Background: The use of immune-modifying biological agents has markedly changed the clinical course and the management of Inflammatory bowel diseases (IBDs). Active post-marketing surveillance programs are fundamental to early recognize expected and unexpected adverse events (AEs), representing a pow...
Saved in:
Main Authors: | Martina Tallarico (Author), Caterina Palleria (Author), Livia Ruffolo (Author), Rocco Spagnuolo (Author), Maria Diana Naturale (Author), Adele Emanuela De Francesco (Author), Caterina De Sarro (Author), Rossella Romeo (Author), Rita Citraro (Author), Patrizia Doldo (Author), Ludovico Abenavoli (Author), Luca Gallelli (Author), Francesco Luzza (Author), Antonio Leo (Author), Giovambattista De Sarro (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region
by: Agnese Gagliardi, et al.
Published: (2022) -
Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis
by: Caterina De Sarro, et al.
Published: (2024) -
Can platelet-rich fibrin act as a natural carrier for antibiotics delivery? A proof-of-concept study for oral surgical procedures
by: Francesco Bennardo, et al.
Published: (2023) -
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders
by: Martina Tallarico, et al.
Published: (2023) -
Change in Diagnosis of <i>Helicobacter pylori</i> Infection in the Treatment-Failure Era
by: Rocco Spagnuolo, et al.
Published: (2024)